The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study
- PMID: 10873088
The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study
Abstract
The protein c-erbB-2, also known as Her2/neu, is a prognostic breast cancer marker assayed in tissue biopsies from women diagnosed with malignant tumors. Present studies suggest that soluble fragments of the c-erbB-2 oncogene may be released from the cell surface and become detectable in patients with carcinoma of the breast. Consequently, the purpose of this study was to assay the c-erbB-2 protein in the saliva and serum of women with and without carcinoma of the breast and to determine whether the protein possesses any diagnostic value. To determine the diagnostic utility of this oncogene, the soluble form of the c-erbB-2 protein was assayed in the saliva and serum using ELISA in three different groups of women. The three groups consisted of 57 healthy women, 41 women with benign breast lesions, and 30 women diagnosed with breast cancer. To compare the relative diagnostic utility of the c-erbB-2 protein, CA 15-3 was also measured. The CA 15-3 measurements served as a "gold standard" by which to compare the c-erbB-2 protein's diagnostic effectiveness. We found c-erbB-2 protein in the saliva and serum of all three groups of women. The salivary and serological levels of c-erbB-2 in the cancer patients, however, were significantly higher (P < 0.001) than the salivary and serum levels of healthy controls and benign tumor patients. Additionally, the c-erbB-2 protein was found to be equal to or to surpass the ability of CA 15-3 to detect patients with carcinoma. The results of the pilot study suggest that the c-erbB-2 protein may have potential use in the initial detection and/or follow-up screening for the recurrence of breast cancer in women.
Similar articles
-
Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.J Oral Pathol Med. 2004 Nov;33(10):589-94. doi: 10.1111/j.1600-0714.2004.00209.x. J Oral Pathol Med. 2004. PMID: 15482324
-
Serum c-erbB-2 protein in breast cancer patients.J Med Assoc Thai. 2000 Aug;83(8):886-93. J Med Assoc Thai. 2000. PMID: 10998842
-
Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.Anticancer Res. 2003 Mar-Apr;23(2A):1043-50. Anticancer Res. 2003. PMID: 12820345
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
-
CA 15-3: uses and limitation as a biomarker for breast cancer.Clin Chim Acta. 2010 Dec 14;411(23-24):1869-74. doi: 10.1016/j.cca.2010.08.039. Epub 2010 Sep 8. Clin Chim Acta. 2010. PMID: 20816948 Review.
Cited by
-
Potential Diagnostic Value of Salivary Tumor Markers in Breast, Lung and Ovarian Cancer: A Preliminary Study.Curr Issues Mol Biol. 2023 Jun 10;45(6):5084-5098. doi: 10.3390/cimb45060323. Curr Issues Mol Biol. 2023. PMID: 37367072 Free PMC article.
-
Ultralow Limit Detection of Soluble HER2 Biomarker in Serum with a Fiber-Optic Ball-Tip Resonator Assisted by a Tilted FBG.ACS Meas Sci Au. 2022 Mar 15;2(4):309-316. doi: 10.1021/acsmeasuresciau.2c00008. eCollection 2022 Aug 17. ACS Meas Sci Au. 2022. PMID: 36785571 Free PMC article.
-
Identification of early biomarkers in saliva in genetically engineered mouse model C(3)1-TAg of breast cancer.Sci Rep. 2022 Jul 7;12(1):11544. doi: 10.1038/s41598-022-14514-1. Sci Rep. 2022. PMID: 35798767 Free PMC article.
-
Saliva Diagnostics.Annu Rev Anal Chem (Palo Alto Calif). 2022 Jun 13;15(1):107-121. doi: 10.1146/annurev-anchem-061020-123959. Annu Rev Anal Chem (Palo Alto Calif). 2022. PMID: 35696523 Free PMC article. Review.
-
Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta-analysis.Cancer Med. 2022 Jul;11(13):2644-2661. doi: 10.1002/cam4.4640. Epub 2022 Mar 22. Cancer Med. 2022. PMID: 35315584 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous